Skip to content

Viridian Therapeutics

US · VRDN #2731 by market cap Listed 1970
29.96 -1.48 -4.71%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Wells Fargo moved from Hold to Buy on 2026-06-29.

Analyst consensus 8 analysts

Buy
Avg price target 40.43 +34.9%
Price target rangecurrent 29.96
Low33.00
Avg40.43
High53.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 Wells Fargo -- Buy 39.00
2026-11-09 H.C. Wainwright -- Buy 40.00
2026-11-05 Wells Fargo -- Buy 34.00
2026-11-05 Wedbush -- Buy 42.00
2026-11-05 Evercore -- Buy 33.00
2026-11-05 H.C. Wainwright -- Buy 40.00
2026-11-05 RBC Capital -- Buy 41.00
2026-11-04 Wedbush -- Buy 42.00
2026-11-04 Goldman Sachs -- Buy 53.00
2026-11-03 Wedbush -- Buy 41.00
2026-10-30 Evercore -- Buy 26.00
2026-10-14 Wells Fargo -- Buy 31.00
2026-10-08 RBC Capital -- Buy 38.00
2026-10-02 LifeSci Capital -- Buy 35.00
2026-09-22 RBC Capital -- Buy 38.00
2026-09-01 Truist Financial -- Buy --
2026-08-19 Goldman Sachs -- Buy 40.00
2026-08-13 Stifel -- Buy 40.00
2026-08-11 Truist Financial -- Buy 39.00
2026-08-10 Evercore -- Buy 26.00
2026-08-07 Truist Financial -- Buy 39.00
2026-08-06 TD Cowen -- Buy --
2026-08-06 LifeSci Capital -- Buy 35.00
2026-08-06 William Blair -- Buy --
2026-08-06 Wedbush -- Buy 41.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-06-29 Wells Fargo Hold → Buy 31.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 -- ±17.64% +15.53% (in line)
2024/Q1 2024-05-08 -- ±13.14% -1.59% (in line)
2023/Q1 2023-05-09 After close ±22.78% -1.21% (in line)
2022/Q4 2023-03-08 -- ±15.86% -10.48% (in line)
2022/Q3 2022-11-14 -- ±19.94% -0.93% (in line)
2022/Q2 2022-08-15 -- -- +49.36%
2022/Q1 2022-05-12 -- ±11.36% +28.03% (beat)
2021/Q4 2022-03-10 -- ±23.63% +5.46% (in line)
2020/Q4 2021-03-25 After close -- +4.75%
2020/Q2 2020-08-05 -- -- -6.84%
2020/Q1 2020-05-07 -- -- +7.27%
2019/Q4 2020-03-11 After close -- -16.65%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Viridian Therapeutics discussion 0 comments

Add a comment